Home News Transgender Youth on Hormone Therapy Risk Substantial Bone Loss back to News
minute read
Among transgender youth who receive puberty-delaying or gender-affirming hormone therapy, bone mineral density (BMD) is lower relative to age-based norms, and this is true regardless of gender assignment at birth.
Topics: Press Coverage
13001 East 17th Place
Suite CG001
Aurora, CO 80045
© 2024 The Regents of the University of Colorado, a body corporate. All rights reserved.
Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.
